• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Insiders Buying American Software And 2 Other Stocks

    7/9/24 7:26:13 AM ET
    $AMSWA
    $ASMB
    $TTSH
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMSWA alert in real time by email

    Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform.

    American Software

    • The Trade: American Software, Inc. (NASDAQ:AMSWA) Director James B Miller Jr acquired a total of 3,718 shares at an average price of $9.15. To acquire these shares, it cost around $34,014.
    • What's Happening: On June 6, American Software posted upbeat quarterly results.
    • What American Software Does: American Software Inc develops enterprise management and supply chain-related software and services.

    Assembly Biosciences

    • The Trade: Assembly Biosciences, Inc. (NASDAQ:ASMB) 10% owner Alexander Schornstein acquired a total of 9,000 shares at an average price of $12.40. To acquire these shares, it cost around $111,631.
    • What's Happening: On June 20, HC Wainwright & Co. analyst Ed Arce reiterated Assembly Biosciences with a Neutral.
    • What Assembly Biosciences Does: Friedman Industries Inc is engaged in the manufacturing and processing of steel products.

    Don’t forget to check out our premarket coverage here

    Tile Shop Holdings

    • The Trade: Tile Shop Holdings, Inc. (NASDAQ:TTSH) 10% owner Pleasant Lake Onshore Feeder Fund LP bought a total of 105,000 shares at an average price of $6.82. To acquire these shares, it cost around $716,190.
    • What's Happening: On May 9, Tile Shop posted better-than-expected quarterly sales.
    • What Tile Shop Holdings Does: Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States.

    Read More: Wall Street’s Most Accurate Analysts Say Buy These 3 Utilities Stocks Delivering High-Dividend Yields

    Get the next $AMSWA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMSWA
    $ASMB
    $TTSH

    CompanyDatePrice TargetRatingAnalyst
    Assembly Biosciences Inc.
    $ASMB
    9/24/2025$38.00Mkt Outperform
    Citizens JMP
    Assembly Biosciences Inc.
    $ASMB
    8/18/2025$50.00Buy
    H.C. Wainwright
    Assembly Biosciences Inc.
    $ASMB
    3/25/2025$31.00Buy
    Guggenheim
    Assembly Biosciences Inc.
    $ASMB
    9/20/2024$2.00 → $35.00Hold → Buy
    Jefferies
    American Software Inc.
    $AMSWA
    8/23/2024$16.00 → $17.00Buy
    Maxim Group
    American Software Inc.
    $AMSWA
    6/6/2022$23.00Neutral → Buy
    B. Riley Securities
    American Software Inc.
    $AMSWA
    12/20/2021$26.00 → $36.00Buy
    Sidoti & Co.
    Tile Shop Holdings Inc.
    $TTSH
    11/19/2021$12.00Buy
    Lake Street
    More analyst ratings

    $AMSWA
    $ASMB
    $TTSH
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Assembly Biosciences Inc.

    SCHEDULE 13G/A - ASSEMBLY BIOSCIENCES, INC. (0001426800) (Subject)

    2/9/26 8:46:31 AM ET
    $ASMB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 15-12G filed by Tile Shop Holdings Inc.

    15-12G - TILE SHOP HOLDINGS, INC. (0001552800) (Filer)

    1/2/26 12:16:12 PM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13D/A filed by Tile Shop Holdings Inc.

    SCHEDULE 13D/A - TILE SHOP HOLDINGS, INC. (0001552800) (Subject)

    12/31/25 10:15:33 AM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    $AMSWA
    $ASMB
    $TTSH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Faw Benjamin

    3 - TILE SHOP HOLDINGS, INC. (0001552800) (Issuer)

    1/15/26 5:30:38 PM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    New insider Lennon Jonathan claimed ownership of 12,859,012 shares (SEC Form 3)

    3 - TILE SHOP HOLDINGS, INC. (0001552800) (Issuer)

    1/15/26 5:30:14 PM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    SEC Form 4 filed by Large owner Fund 1 Investments, Llc

    4 - TILE SHOP HOLDINGS, INC. (0001552800) (Issuer)

    12/16/25 4:15:26 PM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    $AMSWA
    $ASMB
    $TTSH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Gilead Sciences, Inc. bought 2,295,920 shares, increasing direct ownership by 104% to 4,505,391 units (SEC Form 4)

    4 - ASSEMBLY BIOSCIENCES, INC. (0001426800) (Issuer)

    10/3/25 4:30:21 PM ET
    $ASMB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Fund 1 Investments, Llc bought $6,633 worth of shares (1,060 units at $6.26) (SEC Form 4)

    4 - TILE SHOP HOLDINGS, INC. (0001552800) (Issuer)

    6/23/25 4:52:11 PM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    Large owner Fund 1 Investments, Llc bought $6,633 worth of shares (1,060 units at $6.26) (SEC Form 4)

    4 - TILE SHOP HOLDINGS, INC. (0001552800) (Issuer)

    6/23/25 4:50:55 PM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    $AMSWA
    $ASMB
    $TTSH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gilead Sciences Exercises Option to License Assembly Biosciences' Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes

    – Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent Genital Herpes in 25 Years – Gilead Sciences, Inc. (NASDAQ:GILD) and Assembly Biosciences, Inc. (NASDAQ:ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bio's herpes simplex virus (HSV) helicase-primase inhibitor programs, including long-acting investigational candidates ABI-1179 and ABI-5366 for recurrent genital herpes. These represent the first programs Gilead will advance under the ongoing Assembly Bio R&D collaboration, reinforcing the companies' commitment to building a novel antiviral pipeline and driving long-term

    12/22/25 8:00:00 AM ET
    $ASMB
    $GILD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Tile Shop Announces Effective Date for Stock Splits and Delisting from Nasdaq Capital Market

    MINNEAPOLIS, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (NASDAQ:TTSH) ("Tile Shop" or the "Company"), a specialty retailer of natural stone, man-made and luxury vinyl tiles, setting and maintenance materials and related accessories, today announced the effective date for the previously announced Stock Splits (as defined below) and the effective date of the Company's voluntary delisting from The Nasdaq Capital Market. Following the approval of the Company's stockholders at the special meeting of stockholders of the Company held on December 3, 2025, the Company's Board of Directors approved a 1-for-3,000 reverse stock split of the Company's common stock (the "Reverse Stock S

    12/12/25 11:58:36 AM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes

    – 98% reduction in HSV-2 shedding rate, >99% reduction in high viral load shedding rate and 91% reduction in virologically confirmed genital lesion rate observed in 50 mg weekly oral dose of ABI-1179, exceeding expectations for the study – – 76% reduction in HSV-2 shedding rate, 81% reduction in high viral load shedding rate and 88% reduction in virologically confirmed genital lesion rate observed in proof-of-concept test of monthly oral dose of ABI-5366 – – Company to hold conference call today at 6 p.m. ET – SOUTH SAN FRANCISCO, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing innovative therapeutics targeting seri

    12/8/25 4:05:00 PM ET
    $ASMB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMSWA
    $ASMB
    $TTSH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citizens JMP initiated coverage on Assembly Biosciences with a new price target

    Citizens JMP initiated coverage of Assembly Biosciences with a rating of Mkt Outperform and set a new price target of $38.00

    9/24/25 7:55:39 AM ET
    $ASMB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    H.C. Wainwright resumed coverage on Assembly Biosciences with a new price target

    H.C. Wainwright resumed coverage of Assembly Biosciences with a rating of Buy and set a new price target of $50.00

    8/18/25 8:55:27 AM ET
    $ASMB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Guggenheim initiated coverage on Assembly Biosciences with a new price target

    Guggenheim initiated coverage of Assembly Biosciences with a rating of Buy and set a new price target of $31.00

    3/25/25 8:26:24 AM ET
    $ASMB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMSWA
    $ASMB
    $TTSH
    Leadership Updates

    Live Leadership Updates

    View All

    Logility Launches Additional Cutting-Edge Generative AI Capabilities Across its Digital Platform

    AI-first platform accelerates supply chain decision-making with real-time, actionable, and understandable insights for the enterprise supply chain. Logility, a leader in prescriptive supply chain planning solutions, continues to expand its generative AI (GenAI) capabilities across the Logility® Digital Supply Chain Platform, to empower organizations with the tools they need to unlock their data and make their supply chains more efficient, resilient, and competitive. Logility is collaborating with Deloitte Canada in the development of GenAI use cases that address specific supply chain planning challenges in demand, supply, inventory, and order fulfillment to accelerate the expansion of the

    5/6/24 8:00:00 AM ET
    $AMSWA
    Computer Software: Prepackaged Software
    Technology

    Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer

    -- Dr. Gaggar is an experienced industry executive with substantial infectious disease expertise and proven record of successfully leading early- and clinical-stage antiviral programs -- SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that Anuj Gaggar, MD, PhD, has joined the company as chief medical officer. Dr. Gaggar is an infectious disease specialist and seasoned executive whose experience has focused on the development of new therapies in viral diseases including chronic hepatitis B virus (HBV), hepatitis C vi

    11/8/23 8:00:00 AM ET
    $ASMB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    American Software Reports Third Quarter of Fiscal Year 2023 Results

     Subscription Fee Growth of 20% and Adjusted EBITDA Margin of 16% American Software, Inc. (NASDAQ:AMSWA) today reported preliminary financial results for the third quarter of fiscal year 2023. Key Third Quarter Financial Highlights: Subscription fees were $13.0 million for the quarter ended January 31, 2023, a 20% increase compared to $10.9 million for the same period last year, and software license revenues were $1.0 million for both the current and prior period last year. Total revenues for the quarter ended January 31, 2023 decreased 4% to $31.0 million, compared to $32.4 million for the same period of the prior year, principally due to a decline in services revenue. Recurring re

    2/23/23 4:05:00 PM ET
    $AMSWA
    Computer Software: Prepackaged Software
    Technology

    $AMSWA
    $ASMB
    $TTSH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Tile Shop Holdings Inc.

    SC 13G/A - TILE SHOP HOLDINGS, INC. (0001552800) (Subject)

    11/14/24 4:08:07 PM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    SEC Form SC 13G filed by Assembly Biosciences Inc.

    SC 13G - ASSEMBLY BIOSCIENCES, INC. (0001426800) (Subject)

    11/14/24 3:22:29 PM ET
    $ASMB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by American Software Inc.

    SC 13G - AMERICAN SOFTWARE INC (0000713425) (Subject)

    7/26/24 2:51:31 PM ET
    $AMSWA
    Computer Software: Prepackaged Software
    Technology

    $AMSWA
    $ASMB
    $TTSH
    Financials

    Live finance-specific insights

    View All

    Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes

    – 98% reduction in HSV-2 shedding rate, >99% reduction in high viral load shedding rate and 91% reduction in virologically confirmed genital lesion rate observed in 50 mg weekly oral dose of ABI-1179, exceeding expectations for the study – – 76% reduction in HSV-2 shedding rate, 81% reduction in high viral load shedding rate and 88% reduction in virologically confirmed genital lesion rate observed in proof-of-concept test of monthly oral dose of ABI-5366 – – Company to hold conference call today at 6 p.m. ET – SOUTH SAN FRANCISCO, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing innovative therapeutics targeting seri

    12/8/25 4:05:00 PM ET
    $ASMB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Tile Shop to Report Third Quarter 2025 Financial Results

    MINNEAPOLIS, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (NASDAQ:TTSH) (the "Company"), a specialty retailer of natural stone, man-made and luxury vinyl tiles, setting and maintenance materials and related accessories, today announced that the Company will release financial results for the third quarter ended September 30, 2025 on Tuesday November 4, 2025, after the close of the financial markets. The Company will not be hosting a conference call.   The Company intends to use its website, investors.tileshop.com, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Such disclosures will be included on

    10/30/25 8:59:20 PM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary

    The Tile Shop Reports Second Quarter 2025 Results

    MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (NASDAQ:TTSH) (the "Company"), a specialty retailer of natural stone, man-made and luxury vinyl tiles, today announced results for its second quarter ended June 30, 2025.   Second Quarter 2025 Summary Net Sales Decreased 3.4%Comparable Store Sales Decreased 3.5% Gross Margin of 64.4%Net Income of $0.4 Million and Adjusted EBITDA of $4.9 MillionNo Debt Outstanding and $27.8 million of Cash at Quarter-End Management Commentary – Cabell Lolmaugh, CEO "We believe the steps we've taken to expand our assortment of entry level, competitively priced products have contributed to a modest improvement in unit volumes

    8/7/25 7:00:00 AM ET
    $TTSH
    Home Furnishings
    Consumer Discretionary